Conditionally depleting M2-type macrophages with CAR-T cells to target FRβ successfully eliminated the FRβ+ M2-TAMs and induced an influx of tumor-specific CD8+ T cells [244]. The gene discussed is FOLR2; the disease is neoplasm.